The duration of patient's participation to the study is 6 months plus 7 to 14 days.
The study includes the following visits :
* V0: Inclusion visit (Day 0) with the administration of standard of care questionnaires;
* V1: visit at patient's home (Day 0 +7 to 14 days) with the administration of the experimental ESSME questionnaire;
* V2: follow-up visit at 6 months (M6) with the administration of the same standard of care questionnaires than at the inclusion visit;
* V3: visit at patient's home (M6 + 7 to 14 days) with the administration of the experimental ESSME questionnaire.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
man or woman aged 18 to 65 inclusive;
diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria;
patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV);
person who consented to the study;
affiliate or beneficiary of a social security scheme.
You may not be if
patient aged under 18 or over 65;
pregnant or breastfeeding women;
person unable or unwilling to receive a home visit;
person not consenting to the study;
presence of a diagnosis of an associated neurodevelopmental disorder;
presence of a diagnosis of dementia or associated neurodegenerative process;
person with a level of French language insufficient to understand the items.
Clareo Health | Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
